Iris Kamer

4.9k citations

31 papers · 1.9k indexed · h-index 17

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis

Papers in ⓘ

Oncology 23
- Cancer Immunotherapy and Biomarkers 9
- Cancer-related Molecular Pathways 6
- Lung Cancer Research Studies 5
- Cancer Cells and Metastasis 4
Immunology 7
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3

Co-authors: Elena Zelin (2 shared papers)Alexander Faerman (2 shared papers)Svetlana Gorodin (2 shared papers)Paz Einat (2 shared papers)Tzipora Shoshani (2 shared papers)Hagar Kalinski (2 shared papers)Ayelet Chajut (2 shared papers)Andrei V. Budanov (2 shared papers)
Journals: Journal of Clinical Oncology (3 papers)PLoS ONE (3 papers)Archives of Environmental Contamination and Toxicology (2 papers)Journal of Thoracic Oncology (2 papers)Molecular Cancer Research (2 papers)
Partner nations: Israel United States France

In The Last Decade

Iris Kamer

31 papers receiving 1.9k citations

Peers

Countries citing papers authored by Iris Kamer

Since Specialization

Citations

This map shows the geographic impact of Iris Kamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kamer more than expected).

Fields of papers citing papers by Iris Kamer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Kamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kamer. The network helps show where Iris Kamer may publish in the future.

Co-authors

The 25 scholars most cited alongside Iris Kamer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Kamer Line = papers co-authored together Iris Kamer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801 , Involved in Apoptosis Molecular and Cellular Biology ·Tzipora Shoshani, Alexander Faerman, Igor Mett, Elena Zelin, Tamar Tenne, Svetlana Gorodin, Yana Moshel, Shlomo Elbaz, Andrei V. Budanov, Ayelet Chajut, Hagar Kalinski, Iris Kamer, Ada Rozen, Orna Mor, Eli Keshet, Dena Leshkowitz, Paz Einat, Rami Skaliter, Elena Feinstein	2002	479
2	Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability Oncogene ·Andrei V. Budanov, Tzipora Shoshani, Alexander Faerman, Elena Zelin, Iris Kamer, Hagar Kalinski, Svetlana Gorodin, Alla Fishman, Ayelet Chajut, Paz Einat, Rami Skaliter, Andrei V. Gudkov, Peter M Chrumakov, Elena Feinstein	2002	315
3	Proapoptotic BID Is an ATM Effector in the DNA-Damage Response Cell ·Iris Kamer, Rachel Sarig, Yehudit Zaltsman, Hagit Niv, Galia Oberkovitz, Limor Regev, Gal Haimovich, Yaniv Lerenthal, Richard Marcellus, Atan Gross	2005	178
4	Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells Cell Death and Differentiation ·Ira Kogan-Sakin, Yuval Tabach, Y Buganim, Alina Molchadsky, Hilla Solomon, Shalom Madar, Iris Kamer, Perry Stambolsky, Asha Shelly, Naomi Goldfinger, Sandrine Valsesia‐Wittmann, Alain Puisieux, Adi Zundelevich, Einav Nili Gal‐Yam, Camilla Avivi, Iris Barshack, Mariana Brait, David Sidransky, Eytan Domany, Varda Rotter	2010	130
5	Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells The Journal of Experimental Medicine ·Rachel Sarig, Noa Rivlin, Ran Brosh, Chamutal Bornstein, Iris Kamer, Osnat Ezra, Alina Molchadsky, Naomi Goldfinger, Ori Brenner, Varda Rotter	2010	129
6	The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response Nature Cancer ·Merav Cohen, Amir Giladi, Oren Barboy, Pauline Hamon, Baoguo Li, Mor Zada, Anna Gurevich‐Shapiro, Cristian G. Beccaría, Eyal David, Bárbara Maier, Mark Buckup, Iris Kamer, Aleksandra Deczkowska, Jessica Le Bérichel, Jair Bar, Matteo Iannacone, Amos Tanay, Miriam Mérad, Ido Amit	2022	117
7	Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway Stem Cell Research & Therapy ·Christina Katanov, Shalom Lerrer, Yulia Liubomirski, Leonor Leider–Trejo, Tsipi Meshel, Jair Bar, Rotem Feniger-Barish, Iris Kamer, Gali Soria-Artzi, Hadar Kahani, Debabrata Banerjee, Adit Ben‐Baruch	2015	109
8	TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model PLoS ONE ·Orit Leshem, Shalom Madar, Ira Kogan-Sakin, Iris Kamer, Ido Goldstein, Ran Brosh, Yehudit Cohen, Jasmine Jacob‐Hirsch, Marcelo Ehrlich, Shmuel A. Ben‐Sasson, Naomi Goldfinger, Ron Loewenthal, Ephraim Gazit, Varda Rotter, Raanan Berger	2011	90
9	Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer Molecular Cancer Research ·Nicole Paland, Iris Kamer, Ira Kogan-Sakin, Shalom Madar, Naomi Goldfinger, Varda Rotter	2009	56
10	In vitro application of the comet assay for aquatic genotoxicity: considering a primary culture versus a cell line Toxicology in Vitro ·Iris Kamer, Baruch Rinkevich	2002	46
11	Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer Lung Cancer ·Jair Bar, Efrat Ofek, Iris Barshack, Teodor Gottfried, Oranit Zadok, Iris Kamer, Damien Urban, Marina Perelman, Amir Onn	2019	44
12	Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta PLoS ONE ·Shalom Madar, Einav Harel, Ido Goldstein, Yan Stein, Ira Kogan-Sakin, Iris Kamer, Hilla Solomon, Elya Dekel, Perry Tal, Naomi Goldfinger, Gilgi Friedlander, Varda Rotter	2013	36
13	Neoadjuvant pembrolizumab (Pembro) for early stage non-small cell lung cancer (NSCLC): Updated report of a phase I study, MK3475-223. Journal of Clinical Oncology ·Jair Bar, Damien Urban, Efrat Ofek, Aliza Ackerstein, Ilanit Redinsky, Nir Golan, Iris Kamer, David Simansky, Amir Onn, Stephen Raskin, Tiberiu Shulimzon, Michael Peled, Nona Zeitlin, Sharon Halparin, Menucha Jurkowicz, Ramez Abukhalil, Marina Perelman, Alon Ben‐Nun	2019	35
14	Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade Journal for ImmunoTherapy of Cancer ·Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, Itamar Sela, Yehonatan Elon, Shani Raveh Shoval, Galit Yahalom, Iris Kamer, Alona Zer, Ofer Sharon, David P. Carbone, Adam P. Dicker, Jair Bar, Yuval Shaked	2022	25
15	<p>Self-reported sleep quality as prognostic for survival in lung cancer patients</p> Cancer Management and Research ·Teodor Gottfried, Iris Kamer, Iris Salant, Damien Urban, Yaacov Richard Lawrence, Amir Onn, Jair Bar	2020	23
16	Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling Translational Lung Cancer Research ·Iris Kamer, Yael Steuerman, Inbal Daniel‐Meshulam, Gili Perry, Shai Izraeli, Marina Perelman, Nir Golan, David Simansky, Iris Barshack, Alon Ben Nun, Teodor Gottfried, Amir Onn, Irit Gat‐Viks, Jair Bar	2020	22
17	Metallothionein Induction in the RTH-149 Cell Line as an Indicator for Heavy Metal Bioavailability in a Brackish Environment: Assessment by RT-Competitive PCR Archives of Environmental Contamination and Toxicology ·Iris Kamer, Jacob Douek, Moshe Tom, Baruch Rinkevich	2003	19
18	Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit Scientific Reports ·Yael Haberman, Iris Kamer, Amnon Amir, Sapir Goldenberg, Gilat Efroni, Inbal Daniel‐Meshulam, Anastasiya Lobachov, Sameh Daher, Rotem Hadar, Hadas Gantz-Sorotsky, Damien Urban, Tzipi Braun, Jair Bar	2023	12
19	Immunotherapy response modeling by ex-vivo organ culture for lung cancer Cancer Immunology Immunotherapy ·Iris Kamer, Elizabeta Bab-Dinitz, Oranit Zadok, Efrat Ofek, Teodor Gottfried, Inbal Daniel‐Meshulam, Goni Hout‐Siloni, Alon Ben Nun, Iris Barshack, Amir Onn, Jair Bar	2021	12
20	Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling Molecular Cancer Research ·Iris Kamer, Inbal Daniel‐Meshulam, Oranit Zadok, Elizabeta Bab-Dinitz, Gili Perry, Rotem Feniger-Barish, Marina Perelman, Iris Barshack, Alon Ben‐Nun, Amir Onn, Jair Bar	2020	9

About Iris Kamer

Iris Kamer is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis, having authored 31 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related Molecular Pathways (6 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Cancer Research (474 citations), Oncology (670 citations), Molecular Biology (1.2k citations), Immunology (294 citations) and Cell Biology (183 citations). Iris Kamer has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Elena Zelin, Alexander Faerman, Svetlana Gorodin, Paz Einat, Tzipora Shoshani, Hagar Kalinski, Ayelet Chajut, Andrei V. Budanov, Elena Feinstein and Rami Skaliter. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Archives of Environmental Contamination and Toxicology, Journal of Thoracic Oncology and Molecular Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact